Biography
Julian Baker is a prominent figure in the world of biotech investing, recognized for his significant contributions to the finance and investment industry. As of December 5, 2025, his estimated net worth is $7.1 billion. Baker's career began in the late 1980s with Credit Suisse First Boston Corporation's private equity arm, transitioning to a biotech-focused investment partnership with the Tisch family in 1994. In 2000, he co-founded Baker Bros. Advisors LP (BBA) with his brother Felix Baker, a firm specializing in long-term investments in biotechnology companies. Baker's achievements include managing billions in assets and serving on the boards of directors of several public companies, including Acadia Pharmaceuticals, Incyte Corporation, and Denali Therapeutics. His expertise and strategic vision have made him a key player in the biotech sector.